One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
  • [email protected]
  • +1 718 874 1545 (International)
  • +91 78878 22626 (Asia)

More Results

One Stop Shop For Reports One Stop Shop For Reports
  • All Reports
  • All Sectors
    • Chemicals & Materials
      • Advanced Materials
      • Bulk Chemicals
      • Coatings | Paints and Additives
      • Composites
      • Renewable | Speciality chemicals
    • Consumer Goods
      • Baby Products
      • Consumer Electronics
      • Consumer Packaging
      • Cosmetics & Personal Care
      • Homecare & Decor
      • Luxury & premium products
    • Energy and Power
      • Energy Efficiency and Conservation
      • Green | Renewable Energy
      • Non Renewable | Conventional Energy
      • Power Equipment and Devices
    • Life Science
      • Biotechnology
      • Diagnostics
      • Healthcare
      • Healthcare IT
      • Medical Devices & Supplies
      • Pharmaceuticals
    • Food and Beverage
      • Agriculture & Agri Products
      • Beverages
      • Food Ingredients
      • Food Services and Hospitality
      • Nutraceutical | Wellness Food
      • Processed & Frozen Foods
    • Automotive and Transportation
      • Automotive components
      • Automotive Logistics
      • Automotive systems and accessories
    • Information and Communications Technology
      • E Commerce and Outsourcing
      • Entertainment & Media
      • High Tech | Enterprise & Consumer IT
      • Information & Network Security
      • Mobility | Telecom & Wireless
      • Software and Services
    • Semiconductor and Electronics
      • Semiconductor Materials and Components
      • Display Technology
      • Electronics System and Components
      • Emerging technologies
      • Security and Surveillance
      • Sensors and Controls
    • Building and Construction
      • Construction Materials
      • HVAC
      • Residential Construction and Improvement
      • Roads & Highways
    • Manufacturing
      • Manufacturing Services
      • Heavy Manufacturing
      • Packaging
      • Engineering | Equipment and Machinery
  • Who Trust Us
Home ➤ Life Science ➤ Healthcare IT ➤ AI In Pathology Market
AI In Pathology Market
AI In Pathology Market
Published date: March 2024 • Formats:
Request Sample Schedule a Call
  • Home ➤ Life Science ➤ Healthcare IT ➤ AI In Pathology Market

AI In Pathology Market, By Component (Software, Scanner), By Neural Network (Generative Adversarial Networks, Convolutional Neural Networks, Recurrent Neural Networks, Others) By Application (Drug Discovery, Disease Diagnosis And Prognosis, Clinical Workflow, Training And Education), By End User (Pharmaceutical And Biotechnology Companies, Hospitals And Reference Laboratories, Academic And Research Institutes), By Region And Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends, And Forecast 2024-2033

  • Published date: March 2024
  • Report ID: 116370
  • Number of Pages: 282
  • Format:
  • Overview
  • Table of Contents
  • Major Market Players
  • Request a Free Sample
  • Quick Navigation

    • Report Overview
    • Key Takeaways
    • Component Analysis
    • Neural Network Analysis
    • Application Analysis
    • End User Analysis
    • Key Market Segments
    • Market Drivers
    • Market Restraints
    • Market Opportunities
    • Latest Trends
    • Impact of Macroeconomic factors
    • Regional Analysis
    • Key Players Analysis
    • Recent Developments
    • Report Scope

    Report Overview

    The Global AI In Pathology Market size is expected to be worth around USD 119 Billion by 2033, from USD 27.2 Billion in 2023, growing at a CAGR of 15.9% during the forecast period from 2024 to 2033.

    AI In Pathology Market Growth

    The term AI in pathology significantly refers to the integration of artificial intelligence into the field of pathology. This involves study and scrutinization of tissues and cells, analysis of large sets of pathology data using advanced algorithms and machine learning techniques in order to detect, classify and interpret various diseases.

    Further, AI tools assists pathologists to automate monotonous tasks, enhance precision of diagnosis and accelerate analysis of intricate data, resulting into revolutionization by ameliorating efficiency, reducing errors, and providing valuable perception of personalized medicine. For instance, AI applications in pathology involves image identification, predictive modelling for disease prognosis and patern recognition for preliminary detection of oddities. This facilitates time saving and reduction of errors, driving its utilization in laboratories with more cases in the near future.

    The scaling ultimatum for technologically advanced solutions, rising cases of misrecognization and increased funding initiatives for patient care quality improvement and keen emphasis on cost control and efficiency improvement in healthcare facilitites cumulatively drives the growth of the market. However, cost of operation, implementation coupled with interoperability issues may cause hindrance towards market expansion.

    Key Takeaways

    • Based on componets, software segment dominates the market in the year 2023 owing to the rising adoption of AI softwares in pathological workflow.
    • Analysis of neural network reports the strengthening of market occurred by virtue of conventional neural network segment.
    • The escalating use of AI in the process of estimating new drug for individual patients, marks a prominent position of Drug discovery segment in the marketplace.
    • The rising pervasiveness of diseases makes hospital and reference laboratories segment to dominate the global AI in pathology market
    • Asia-Pacific to dominate the market owing to high adoption of artificial intelligence in diverse pathological work in the countries like India and China.

    Component Analysis

    Software segments is marked as a major leader

    Based on component, the market for AI in pathology is fragmented into software and scanner segment, where software segment is known to dominate the market marking its position as a major leader in 2023. The segments’ domination is a reflection of escalating adoption of artificial intelligence software in pathology as the technology assists the pathologists to accelerate the outcomes, better understanding of patient’s condition, and plan recovery medication within minimal period of time.

    In addition, the segment gets an optimistic push as it has the ability to store patient health information and report retrievel efficiently aided by artificial intelligence. Thus, these multifaceted factors shapes the AI in pathologys’ market dynamics in recent years, making the segment to grab a measurable market share of 74.5% in the year 2023.

    Neural Network Analysis

    Ease in the workflow of pathologists makes conventional neural network segment dominating

    The market for AI in pathology is broadly categorized into Generative adversarial networks, Convolutional neural networks, Conventional neural network, Recurrent neural networks and other segments, depending on analysis of neural network. The market experiences an expanding climate driven by conventional neural network segment capturing a commanding market share of 45.2% in the year 2023.

    The segment improves workflow efficiency of pathologists by virtue of the ability of AI to image examine pathology slides and identify patterns in tissues. This allow the pathologist to maintain a keen emphasis on clinical trials and results interpretation. All these factors togetherly leads to heightening application of artificial intelligence in pathology in the upcoming future.

    Application Analysis

    AI enhances safety and efficacy of drugs for end users

    With respect to applications, the market is fragmented into Drug discovery, Disease diagnosis and prognosis, Clinical workflow and Training and education segment. Amongst these, a laudable market share of 46.7% is grabbed by drug discovery segment by virtue of notable cases of illicit drug across the globe. Further, AI helps to estimate effectiveness of new drug for individual patient as it can scrutinize large population data and recognize pattern and trends.

    In addition to this, the demand for AI during the study period is boosted as the safety and effectiveness of drugs for consumers up scaled. This is due to the utilization of AI to recognize the origin of disorders, proteins and vitamins by the researchers to a greater extent.

    • According to International Agency for Research on Cancer, around 14.1 million new cases were estimated in 2012 and is further expected to increase to more than 20 million each year by 2030.

    End User Analysis

    Market is pushed forward by rising pathology cases

    Based on end use, the market is bifurcated into Pharmaceutical and Biotechnology companies, Hospitals and Reference laboratories and Academic and Research Institutes. Hospitals and Reference laboratories segment captures a commendable market revenue share of 58.4% in the year 2023. This admirable market presence has expideted due to growing number of cases in recent times, which are further precisely handled by hospital and reference laboratories. With the loaded pathology workflow the demand for AI driven solutions enhances providing persistent outcomes in compact period of time.

    Additionally, hospitals do not require more pathologists to manage rising cases, as AI has the ability to multitask and provide satisfactory results, creating new opportunities for global market in the near future.

    • According to 2017 to 2020 statistics, the number of pathology specimens tested remotely in Jianghua country reached 10,394 with an annual increase of more than 10%.

    AI In Pathology Market Size

    Key Market Segments

    By Component

    • Software
    • Scanners

    By Neural Network

    • Generative adversarial networks
    • Convolutional neural networks
    • Conventional neural network
    • Recurrent neural networks
    • Other

    By Application

    • Drug discovery
    • Disease diagnosis and prognosis
    • Clinical workflow
    • Training and education

    By End User

    • Pharmaceutical and Biotechnology companies
    • Hospitals and Reference laboratories
    • Academic and Research Institutes

    Market Drivers

    Multifaceted AI features drives the market reach

    A synergy is established between artificial technology and modern pathology due to the advancements in pattern recognition and image processing. Image classification proved its effectiveness by virtue of deep convolutional neural networks, allowing digital pathology to ameliorate slide scanning approaches. The tedious tasks associated with pathology is pulled back on track by computer assisted technologies assisting in grading, staging, classifying and quantifying responses to treatment. Neural network algorithms play a pivotal role in case of vast data input or high quality training sets, using a digitized database exceeding 100,000 clinical photos of skin disease.

    The categorization of skin lesions in comparison to current pathology quality standards is effectively proceeded by deep convolutional neural network. Amongst diverse computational image recognition tasks exceptional outcomes are brought by deep learning platform precisely segmenting task including epithelia, nuclei, cell cycle characterization, mitosis quantification, immune infiltration and tumor grading. Thus, digital pathology lab results in more precise drug response prediction and prognosis of this concealed disease over time, scaling demand for AI thereby driving the market growth.

    Market Restraints

    High cost and scarcity of trained professionals

    The adoption of AI is anticipated to impede with the scaling investments required to establish digital pathology. These heavily budgeted setup becomes affordable for substantial capital budget hospitals, while the pathologies and academic institutes with finite budget restricts themselves to adopt these advanced technologies. In addition to this, trained personnel is required for efficient operation and maintenance of digital pathology system. Thus, the dearth of skilled professionals and high cost of AI implementation in pathologies combinely hamper the growth of the market.

    • To exemplify, an approximate cost of the USD 500,000 to the USD 1,500,000 is required for a typical pathology system comprising a slide scanner, an image server and a software

    Market Opportunities

    Rising prevalence of diseases

    The demand for pathology services boosted noticeably with the rising pervasiveness of diseases. The laboratories dealing with limited workforce faces abundant challenges for handling rising volume of specimens. These up scales an ultimatum for AI based solutions in laboratories for multitasking diverse workflow simultaneously. Patients at remote distance can now share the desired information beyond geographical boundaries with the incorporation of artificial intelligence in pathologies.

    Dearth of trained pathologists

    In addition, there arises a shortage of trained pathologists with the increased workload resulting in enhanced stress level and delays in diagnosis. Thus, this burden can be smoothly alleviated by AI in pathology assisting in automation of  routine tasks, providing decision support, and assists in slide examination. Thus, this shortage necessitates the need for AI in pathology to provide remote pathological consultation and services towards patients, offering wealthy opportunities for market growth.

    Latest Trends

    Development of AI powered diagnostic tools

    AI based diagnostic tools and solutions ranging from automated screening algorithms for cancer detection to advanced decision support technology for analysis of histopathologies, assists the pathologists to precisely detect and classify diseases.

    AI for Predictive Pathology and Precision Medicine

    Disease continuance, treatment response and outcome of patients can be predicted by analyzing large scale proteomic, genomic and clinical data aided by AI algorithms. Thus, AI is popularly utilized for predictive pathology and precision medicine applications, enabling personalized treatment strategies.

    Impact of Macroeconomic factors

    A combination of macroeconomic factors influence the growth of AI in pathology market. The market is primarily affected by the changes in demographic factors including rising prevalence of diseases coupled with growing elderly population. With the rise in these facets, there necessitates a demand for pathology services such as AI powered diagnostic services to underpin detection and treatment of diseases at the onset stage. In addition, the adoption of AI in a country is heavily influenced by the level of healthcare expenditure. Higher the healthcare spending more are the resources accessible towards the population including AI based pathology services.

    Regional Analysis

    Asia-Pacific bolstered its position in AI based pathology market

    The elevating implementation of artificial intelligence in healthcare sectors especially in the regions like India and China, leads Asia-Pacific region to gain popularity over other geographies. The region being at the forefront captures a valuable market share of 31.4%, commanding the global AI in pathology market. The rising capability of AI in pathology to complete mundane tasks in compact period of time save pathologists to spend long time intervals in pathology work. The region further show excellence due to the presence of lower level pathologists demanding the adoption of artificial intelligence to carry out diverse tasks allotted for pathologists.

    • The remote pathology diagnosis platform at Xiangya Hospital Central South University(China) has completed 10,254 cases of remote pathology consultation by the end of April 2019.

    AI In Pathology Market Regions

    Key Regions and Countries

    • North America
      • US
      • Canada
    • Europe
      • Germany
      • France
      • The UK
      • Spain
      • Italy
      • Russia
      • Netherland
      • Rest of Europe
    • Asia Pacific
      • China
      • Japan
      • South Korea
      • India
      • New Zealand
      • Singapore
      • Thailand
      • Vietnam
      • Rest of APAC
    • Latin America
      • Brazil
      • Mexico
      • Rest of Latin America
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Rest of MEA

    Key Players Analysis

    The major companies are focusing on growth strategies such as product developments, new product approvals, and mergers & acquisitions to enhance their share of the worldwide AI in pathology market. For Instance, a collaboration was brought into account between 3DHISTECH and Epredia to launch a pathology innovation incubator with the aim to expedite the progress in cancer diagnostics. Some of the key market players in the AI in pathology market includes Akoya Biosciences, Indica Labs, PathAI, etc.

    Market Key Players

    • Aiforia Technologies
    • Ibex Medical Analytics
    • PROSCIA
    • Roche Tissue Diagnostics
    • Visiopharm
    • Deep Bio
    • Mindpeak
    • Hologic
    • Aiosyn
    • Lumea

    Recent Developments

    • In April 2023: An agreement was signed by Indica Labs Inc.(US) with Lunit Inc.(Sout Korea). The agreement comprised statements related to the provision of a fully interoperable solution between Lunit’s suite of AI pathology products and Indica labs’ HALO AP image management software platform.
    • In November 2023: Leica Biosystems partnered with hospitals and laboratories across the globe to utilize innovative digital pathology workflows. Leica selected paige to supply their Aperio GT 450 digital pathology slide scanners with view and manage digital pathology images software coupled with a range of embedded AI technologies.

    Report Scope

    Report Features Description
    Market Value (2023) USD 27.2 Billion
    Forecast Revenue (2033) USD 119.0 Billion
    CAGR (2024-2033) 15.9%
    Base Year for Estimation 2023
    Historic Period 2018-2022
    Forecast Period 2024-2033
    Report Coverage Revenue Forecast, Market Dynamics, COVID-19 Impact, Competitive Landscape, Recent Developments
    Segments Covered By Component (Software, Scanner), By Neural Network (Generative adversarial networks, Convolutional neural networks, Recurrent neural networks, Others) By Application (Drug discovery, Disease diagnosis and prognosis, Clinical workflow, Training and education), By End User (Pharmaceutical and Biotechnology companies, Hospitals and Reference laboratories, Academic and Research Institutes)
    Regional Analysis North America – US, Canada; Europe – Germany, France, The UK, Spain, Italy, Russia, Netherland, Rest of Europe; APAC – China, Japan, South Korea, India, New Zealand, Singapore, Thailand, Vietnam, Rest of APAC; Latin America – Brazil, Mexico, Rest of Latin America; Middle East & Africa – South Africa, Saudi Arabia, UAE, Rest of MEA.
    Competitive Landscape Aiforia Technologies, Ibex Medical Analytics, PROSCIA, Roche Tissue Diagnostics, Visiopharm, Deep Bio, Mindpeak, Hologic, Aiosyn, Lumea
    Customization Scope Customization for segments, region/country-level will be provided. Moreover, additional customization can be done based on the requirements.
    Purchase Options We have three licenses to opt for Single User License, Multi-User License (Up to 5 Users), Corporate Use License (Unlimited User and Printable PDF)
    AI In Pathology Market
    AI In Pathology Market
    Published date: March 2024
    add_shopping_cartBuy Now get_appDownload Sample
    keyboard_arrow_up
    • Aiforia Technologies
    • Ibex Medical Analytics
    • PROSCIA
    • Roche Tissue Diagnostics
    • Visiopharm
    • Deep Bio
    • Mindpeak
    • Hologic
    • Aiosyn
    • Lumea
  • settingsSettings

Related Reports

  • AI In Animal Health Market
  • AI In Bioinformatics Market
  • AI In Breast Imaging Market
  • AI In Cancer Market
  • AI In Medical Coding Market
  • Generative AI in Healthcare Market

Our Clients

  • Our Clients
Inquiry Before Buying

AI In Pathology Market
  • 116370
  • March 2024
    • ★★★★★
      ★★★★★
    • (142)
add_shopping_cart Buy Now
Trusted by more than 17382 organizations globally
  • Client Logo
  • Client Logo
  • Client Logo
✖
Request a Sample Report
We'll get back to you as quickly as possible

Single User
$6,000
$3,999
USD / per unit
save 24%
Multi User
$8,000
$5,999
USD / per unit
save 28%
Corporate User
$10,000
$6,999
USD / per unit
save 32%
e-Access
Report Library Access
Data Set (Excel)
Print
Company Profile Library Access
Interactive Dashboard
Free Custumization No up to 10 hrs work up to 30 hrs work
Accessibility 1 User 2-5 User Unlimited
Analyst Support up to 20 hrs up to 40 hrs up to 50 hrs
Benefit Up to 20% off on next purchase Up to 25% off on next purchase Up to 30% off on next purchase
Buy Now ($ 3,999) Buy Now ($ 5,999) Buy Now ($ 6,999)
  • location_on420 Lexington Avenue, Suite 300 New York City, NY 10170,
    United States
  • phone+1 718 874 1545 (International)
  • phone+91 78878 22626 (Asia)
  • email[email protected]
  • Facebook Logo
  • Twitter Logo
  • LinkedIn Logo
Find Help
  • Contact Us
  • How to Order
Legal
  • Privacy Policy
  • Refund Policy
  • Frequently Asked Questions
  • Terms and Conditions
Explore
  • About Us
  • All Reports
  • All Sectors
  • Infographics
  • Statistics and Facts
  • Companies
Secured Payment Options
Secured Payment Options

© 2025 Market.Us. All Rights Reserved.